A genetic test cannot confirm or rule out autism. Autism is identified through a careful developmental assessment, not a blood or saliva test. Yet genetic testing for autistic children can sometimes answer a different, deeply practical question: is there an underlying genetic change that may help explain a child’s developmental profile, guide health checks, or inform the wider family?
For parents already carrying the weight of appointments, school concerns and long waiting lists, that distinction matters. Testing is not a promise of an answer and it should never be presented as one. But when it is offered with clear consent, appropriate counselling and follow-up, it may provide useful information that families have every right to understand.
What genetic testing for autistic children is designed to find
Genes carry instructions for how the body develops and functions. Small changes in genetic material are common in all people. Some changes are harmless, while others are associated with particular developmental, learning or health differences.
The tests most often discussed in the context of autism include chromosomal microarray testing, which looks for missing or extra sections of DNA, Fragile X testing in relevant circumstances, and sequencing tests that examine many genes at once. The type of test offered depends on a child’s individual history, developmental profile, physical health, family history and the clinical question being asked.
A result may identify a genetic condition associated with autism or developmental disability. This can help a family and their care team consider whether particular health monitoring is relevant, such as checks relating to seizures, sleep, hearing, heart health or other concerns. It may also give parents a clearer basis for discussing recurrence chances in future pregnancies or for other relatives who are considering testing.
Research shows why expectations need to be realistic. In a study of 258 children with autism spectrum disorder, chromosomal microarray testing found a clinically significant result in 9.3 per cent of children and whole-exome sequencing in 8.4 per cent. Using both approaches increased the yield, but most children did not receive a definitive genetic finding (Tammimies et al., JAMA, 2015).
That is not a failure. A child does not need a named genetic finding for their needs, strengths and support requirements to be real. Genetic testing is one part of the picture, not a measure of whether a child is ‘really’ autistic or deserving of support.
What a result can mean - and what it cannot
A result may be described as positive, negative or uncertain. Those labels can sound more final than they are, so families deserve plain language.
A positive or diagnostic result means the test has identified a genetic change currently known to be associated with a condition. It may offer a useful explanation and point to further discussions about health or family planning. It does not predict a child’s personality, abilities, future independence or the kind of life they will lead. Children with the same genetic finding can have very different profiles.
A negative result means the test did not find a currently identifiable explanation. It does not mean there is no genetic contribution to autism. Autism is highly heritable and genetically complex, with many genetic influences involved across the population (Grove et al., Nature Genetics, 2019). Science also changes: a result that cannot be explained today may be better understood as research advances.
The result that can be hardest to receive is a variant of uncertain significance, often shortened to VUS. This means a genetic change was found, but researchers do not yet have enough evidence to know whether it is relevant to the child’s development or health. A VUS should not be treated as a diagnosis or used alone to make major medical decisions. In some cases, testing parents can help clarify whether the variant was inherited or arose newly, but it may remain uncertain.
Families may also be asked whether they want to receive information unrelated to the original reason for testing. Sequencing can occasionally reveal a genetic finding connected to another health condition. Laboratories follow consent processes for such findings, and families can ask exactly what may be reported before agreeing to a test. The American College of Medical Genetics and Genomics maintains recommendations on the types of medically actionable secondary findings that laboratories may consider reporting (Miller et al., Genetics in Medicine, 2023).
When should a family consider testing?
There is no single answer for every autistic child. A GP, paediatrician or another qualified health professional may raise genetic testing where autism occurs alongside intellectual disability, global developmental delay, epilepsy, congenital differences, unusual growth patterns, a strong family history, or other medical concerns. These features can affect which test, if any, is most suitable.
Professional guidance supports offering a genetic evaluation to people with autism, while recognising that the investigation should be tailored to the individual (Hyman et al., Pediatrics, 2020). For children with developmental delay, intellectual disability or congenital anomalies, the American College of Medical Genetics and Genomics has also concluded that exome or genome sequencing may be considered as a first- or second-tier test because it can have a higher diagnostic yield than older approaches in selected groups (Manickam et al., Genetics in Medicine, 2021).
Guidelines are helpful, but they do not replace an individual discussion. In Australia, availability, cost and public funding arrangements can differ between states, territories and services. Ask the referring clinician what test is proposed, why it is appropriate for your child, what the out-of-pocket costs may be, and what support will be available when results arrive.
Questions worth taking to the appointment
The most useful question is not simply, ‘Should we test?’ It is, ‘What decision or care question could this test help us with?’ A family may want to ask whether the test could change health monitoring, whether it might identify information relevant to siblings or parents, and how long results are likely to take.
It is also reasonable to ask what a negative or uncertain result would mean, whether parental samples are recommended, and whether the laboratory may retain the sample or data. Genetic information can feel personal because it may have implications beyond one child. Families should have time to consider consent and should not feel pressured to decide during a single appointment.
If a result identifies a genetic condition, ask who will explain the finding in everyday language and whether a referral for genetic counselling is appropriate. Counselling does not tell a family what choice to make. It helps them understand the information, its limits and its possible implications.
Better information is part of better support
Australia’s autism and ADHD families are too often left to assemble fragmented information while trying to secure their children’s future. Research that clarifies genetics can contribute to better care pathways and more informed policy, but it must be conducted ethically and communicated honestly. It must not be used to revive harmful ideas that autism is a problem to be eliminated, or to suggest that a genetic result defines a child.
The Australian Autism ADHD Foundation supports independent, ethics-approved research and clearer public education because families deserve evidence they can use, not speculation dressed up as certainty. Sharing reliable information, supporting research and asking policy makers to fund equitable access to multidisciplinary support are practical ways to push back against a system that too often leaves families waiting.
If genetic testing is being considered, take your questions to the appointment, write down the answers, and give yourself permission to ask for an explanation again. Clear information is not a luxury for families under pressure. It is part of fairer care.
This article is general information only. Please speak with your GP or another qualified health professional about your own situation.